Objective: Endometriosis-associated abdominal wall cancer (EAAWC) is rare, and few reports are available. This article provides a review of reports in the literature on the pathology, diagnosis, management, and outcome of patients with EAAWC. Method: We performed a review of existing reports in the English language literature on cancer arising from abdominal wall endometriosis. MEDLINE and EMBASE searches were conducted for articles published from September 1986 to August 2014 using combinations of medical subject heading terms. Results: We identified 26 articles reporting on EAAWC and added 1 patient who was treated at our institution. In all of these patients, EAAWC was described after uterine surgery (mostly cesarean section). The delay between the first surgery and the diagnosis of malignant disease was more than 20 years. Clear cell carcinoma was the most common histology, followed by endometrioid carcinoma. Death was described in 44% of women within a few months of diagnosis. Conclusions: Endometriosis-associated abdominal wall cancer is rare and aggressive. It seems to be associated with cesarean section, and it shows poor prognosis. The mainstay of treatment remains extensive surgery and chemotherapy.
ndometriotic implants in the anterior abdominal wall are among the most common locations of endometriosis outside of the peritoneal cavity. They are considered to be the result of direct implantation of viable endometrial cells into subcutaneous or subfascial spaces that are exposed by surgical incisions on the abdominal wall. Abdominal localizations of these implants are typically observed after cesarean section (0.03%Y0.4%) or hysterectomy, although they have also been reported in association with episiotomy, trocar scars, appendectomy, and hernia repair scars.
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The typical manifestations of endometriosis in surgical scars are focal cyclic pain and a slow-growing mass. Only 20% of cases of endometriosis of the abdominal wall are associated with peritoneal endometriosis. 2 Malignant transformation of an endometriosis lesion has been described. In 1925, Sampson 4 defined the following 3 criteria to diagnose the malignant transformation of endometriosis: the association of endometriosis and neoplastic tissue within the tumor, endometrial histology, and the absence of additional tumors. Scott 5 added a fourth criterion of metaplasia between benign endometriosis and carcinoma.
Malignant transformation of ovarian endometriosis has been well documented. Cases of extraovarian malignant transformation comprise approximately 20% of all cases, with a preference for rectal localization. 6 However, isolated malignant lesions on the peritoneum, vagina, colon, and abdominal wall arising from endometriosis have also been described.
We conducted a systematic review of the literature to identify all published cases, histology types, proposed treatments, and prognoses, including a case of endometrioid carcinoma (EC) arising from abdominal wall endometriosis for which we recently assessed the prognosis.
MATERIALS AND METHODS
The present literature review was conducted according to the PRISMA guidelines for systematic reviews. 7 
Sources
This article is a review of existing reports in the English language literature on cancer arising from abdominal wall endometriosis. MEDLINE and EMBASE searches were conducted for articles published from September 1986 to August 2014 using combinations of medical subject heading terms. The key words used for this search were as follows: ''abdominal wall endometriosis,'' ''carcinoma,'' and ''endometriosis malignant transformation.'' All pertinent articles were retrieved, and the relative reference lists were systematically reviewed to identify further reports that could be included in this analysis. Moreover, review articles published on cancer and endometriosis during the same time span were consulted, and their reference lists were searched for potential additional studies. No attempt was made to identify unpublished studies.
Study Selection
Original articles and case reports were selected. Abstracts from scientific meetings were not included. Given the rarity of this type of tumor, the quality of the studies was not evaluated.
Data Extraction
Studies were categorized based on research design. The year of publication, location, setting, number and clinical characteristics of the recruited subjects, surgical history including cesarean section and other uterine surgeries (dilatation and curettage, myomectomy, supracervical hysterectomy, and total hysterectomy), cancer histology, treatment, and survival rate were extracted. In the case of a description of living patients at the time of publication, the authors were contacted by e-mail to obtain updated information.
Data Analysis
The main objective of this study was to obtain data on the prognosis and survival of patients with cancer arising from abdominal wall endometriosis. Survival estimates were plotted using the Kaplan-Meier method. Statistical analyses, including Kaplan-Meier curves, were plotted using SPSS version 20 (IMB SPSS Inc, Armonk, NY) software.
RESULTS
The MEDLINE search identified 26 records, which were all case reports. They were included in the final analysis and were eligible for this review.
A total of 26 case reports of malignant transformation of abdominal wall endometriosis were published between 1986 and 2014, 8Y32 and we provided case number 27. At the time each report was published, 11 patients died from the disease. With the aim of obtaining recent information on 14 patients who were alive at the time of publication, we sent 27 e-mails to 15 corresponding authors. We received 8 responses, and updated clinical information was available for only 5 patients. All cases included in this review are summarized in Table 1 .
The mean age of the patients at the time of diagnosis was 47 years (range of 38Y60 years) ( Table 2 ). All patients received medical consultations after the appearance of a mass, which was sometimes associated with cyclic or continuous pain at the site of the abdominal scar. A total of 24 (89%) of the 27 patients underwent 1 (41%) or 2 (48%) cesarean sections. Only 3 patients underwent laparotomy, which was performed for uterine perforation during curettage, myomectomy, and open tubal sterilization ( Table 2) . Before cancer developed, 5 patients underwent additional surgery to remove a nodule of endometriosis from the site of a cesarean section scar. The mean delay between the first surgery and the diagnosis of the malignant disease of the abdominal wall was 21 years (range of 8-41 years) ( Table 2) .
The most common histological type was clear cell carcinoma (CCC), which was reported in 63% (n = 17) of the patients. Other histological types included EC, which was reported in 22% (n = 6) of the patients; serous papillary carcinoma (SPC), which was reported in 7% (n = 2); and sarcoma, which was described in 1 patient. In 1 patient, concomitant CCC and EC lesions were reported. Only 66% of the patients reported the coexistence of endometriosis implants with cancer ( Table 3) .
As a surgical treatment, a wide local excision of the abdominal scar was described in all patients. To repair the parietal defect, most authors used a mesh 14,18,19,21Y23,26,29Y31 or pedicle skin-muscle 16 flap. In the majority of cases, a total hysterectomy was performed with bilateral salpingooophorectomy, 8, 9, 17, 19, 32 omentectomy, 12, 25, 29 and pelvic lymphadenectomy. 21, 22, 28 When hysterectomy was not performed, curettage to exclude primary endometrial carcinoma was performed. 14, 17, 23, 26, 32 Chemotherapy was administered to 74% of the patients. Treatment followed surgery in 85% of the patients. The protocol most commonly used was a combination of carboplatin and paclitaxel. The use of targeted radiotherapy was performed in less than 30% of the patients.
Updated clinical follow-up information was obtained for 24 patients. The mean follow-up time was 24 months, with a range of 6 to 60 months. Death occurred in 44% of the women (n = 11) between 6 and 48 months after diagnosis. As shown on the Kaplan-Meier survival curve (Fig. 1) , the median survival time after diagnosis was 30 months.
DISCUSSION
Endometriosis-associated abdominal wall cancer (EAAWC) is a rare event, and less than 30 cases have been reported in the literature. All reported cases show that a previous surgical procedure with endometrial cavity opening may be a predisposing factor to developingendometriosis implants in the abdominal wall. Cesarean section is the most frequent surgical procedure associated with abdominalwall endometriosis, and it also seems to be the most frequent surgery reported in cases of cancer derived from abdominal endometriosis implants. In 66% of the patients, the coexistence of benign endometriosis with cancer was reported. In addition, 5 patients reported clinical and histological confirmation of a previous abdominal nodule of endometriosis without associated cancer, although they would develop cancer in the same anatomical site within a few years. The long median time between the first uterine surgery (mainly cesarean section) and the diagnosis of cancer suggests a slow evolution of the disease, although the lesions were large in size at the time of diagnosis. The typical complaint was a mass in the abdominal wall adjacent to a scar from a previous surgery (described in 100% of patients). Abdominal pain was often described (88% of patients) and was either cyclical, corresponding with the menstrual cycles, or permanent. In relation to these symptoms, the following differential diagnoses were often mentioned: hernia, abscess, hematoma, soft tissue tumor, primary neoplasia, metastasis, and endometriotic implants. The latter was often not fully considered at the beginning of the diagnostic process, probably explaining the delay in diagnosis in some cases.
The histological type most represented was CCC (63% of the patients), followed by EC (22% of patients). Numerous case reports, case series, and epidemiological studies have established that endometriosis-associated malignancies often show clear cell or endometrioid histopathology. A study by Modesitt et al 33 examined 115 cases of endometriosis with concurrent intraperitoneal cancers, 18% of which were extraovarian tumors. Clear cell and endometrioid microscopic patterns were most frequently encountered. Importantly, the study by Modesitt et al 33 noted the presence of ''transition points'' in many of these tumors, where a benign endometriotic gland was observed to merge with atypical and overtly malignant glands. These findings support the idea that endometriosis may undergo malignant transformation rather than simply being a coexisting diagnosis. Our results indicate that this histopathological association has also been reported in cancers arising from endometriosis of the abdominal wall.
The mainstay of treatment remains surgical staging/ debulking. The creation of a wide and complete excision to obtain healthy margins has been frequently described. Depending on the size of the tumor, it is sometimes necessary to use mesh to reconstruct the abdominal wall. The use of adjuvant radiotherapy and chemotherapy has been reported, but different treatment protocols and schedules have been used. However, chemotherapy based on a combination of carboplatin and paclitaxel has been most frequently described. Most authors have adapted the standard treatment protocol for endometriosis-associated ovarian cancer. The rarity of EAAWC has limited the execution of prospective trials, and current management is mainly based on experience derived from case reports.
The prognosis of evaluated patients seems to be poor, although the limited number of cases and different treatment strategies and cancer histology types limit the formation of extensive conclusions. The present review revealed a median survival time of 30 months, with a confidence interval of between 0 and 61 months. The follow-up time was highly variable among studies and, in most cases, it was less than 5 years. Thus, an estimate of the 5-year survival rate was not statistically justified in this review.
In contrast, endometriosis-associated ovarian cancer usually occurs in younger women, has favorable outcomes, and presents as a low-grade tumor. 34 Thus, EAAWC seems to be more aggressive. One reason for this difference may be the fact that abdominal wall cancer seems to be more locally advanced at the time of diagnosis. In addition, 3 patients showed lymph node invasion and died within 30 months after surgery, 23, 24, 31 suggesting that lymph node invasion is a negative prognostic factor for patient survival.
Results from the present study should be interpreted within the context and limitations of our data. We included only case reports, which may be subject to bias because cases involving complications are generally documented more frequently than those with a favorable progression. However, this is the first review to provide insight into the course of EAAWC and contribute to current knowledge of the evolution of this type of cancer to date.
In conclusion, EAAWC is a rare but aggressive pathology. Although abdominal wall endometriosis seems to be iatrogenic in most cases, the reasons for the evolution of this type of cancer are largely unknown. Unfortunately, the limited number of patients reported reduces the statistical value of Kaplan-Meier analysis, and all considerations are far from conclusive. To obtain more information about the prognosis of EAAWC, a larger number of patients with a follow-up of at least 5 years should be analyzed.
